SAPK2a
[also termed p38 (Han et al., 1994) , p40 1 Corresponding authors (Freshney et al., 1994) , RK (Rouse et al., 1994) , CSBP M.Goedert and A.Cuenda contributed equally to this work and Mxi2 (Zervos et al., 1995) ] is inhibited very specifically by the pyridinyl imidazoles SB A cDNA was cloned that encodes human stress-activ-203580 and SB 202190 ; Cuenda et al., ated protein kinase-4 (SAPK4), a novel MAP kinase 1995; reviewed in Cohen, 1997) which have been exploited family member whose amino acid sequence is~60%
to identify several physiological substrates. These include identical to that of the other three SAP kinases which four protein kinases, namely MAP kinase-activated protein contain a TGY motif in their activation domain. The kinase-2 (MAPKAP-K2, Rouse et al., 1994) and the mRNA encoding SAPK4 was found to be widely disclosely related MAPKAP-K3 (Clifton et al., 1996 ; tributed in human tissues. When expressed in KB cells, McLaughlin et al., 1996; Sithanandam et al., 1996) , as SAPK4 was activated in response to cellular stresses well as MAP kinase interacting protein kinases-1 and -2 and pro-inflammatory cytokines, in a manner similar (Mnk1 and Mnk2) (Fukunaga and Hunter, 1997 ; to other SAPKs. SAPK4 was activated in vitro by Waskiewicz et al., 1997) .
SKK3 (also called MKK6) or when co-transfected with
Physiological substrates of MAPKAP-K2/K3 include SKK3 into COS cells. SKK3 was the only activator of heat shock protein (HSP) 27 (Cuenda et al., 1995; Huot SAPK4 that was induced when KB cells were exposed et al., 1995) and the transcription factor CREB (Tan to a cellular stress or stimulated with interleukin-1. et al., 1996) , whereas transcription factor eIF4E is a These findings indicate that SKK3 mediates the activphysiological substrate of Mnk1/2 (Waskiewicz et al., ation of SAPK4. The substrate specificity of SAPK4 1997) . SAPK2a also mediates the stress-induced phosin vitro was similar to that of SAPK3. Both enzymes phorylation and activation of the CEBPβ-related transcripphosphorylated the transcription factors ATF2, Elk-1 tion factor CHOP (Wang and Ron, 1996) and the ternary and SAP-1 at similar rates, but were far less effective complex factor Elk-1 (Price et al., 1996) . than SAPK2a (also called RK/p38) or SAPK2b (also Based on the effects of SB 203580, the activation of called p38β) in activating MAPKAP kinase-2 and SAPK2a is rate-limiting in the LPS-induced production MAPKAP kinase-3. Unlike SAPK1 (also called JNK), of IL1 and TNF in monocytes , in the SAPK3 and SAPK4 did not phosphorylate the activ-TNF-stimulated transcription of IL6 and GM-CSF in ation domain of c-Jun. Unlike SAPK2a and SAPK2b, fibroblasts (Beyaert et al., 1996) , in the IL1-induced SAPK4 and SAPK3 were not inhibited by the drugs stimulation of glucose uptake in epithelial cells (Gould SB 203580 and SB 202190. Our results suggest that et al., 1995) , in collagen-induced platelet aggregation cellular functions previously attributed to SAPK1 and/ (Saklatvala et al., 1996) and in the stress-induced transcripor SAPK2 may be mediated by SAPK3 or SAPK4.
Introduction
Recently, two additional SAP kinases were identified, called SAPK2b [or p38β ] and SAPK3 Four mitogen-activated protein (MAP) kinase family mem- (Mertens et al., 1996) [also called ERK6 (Lechner et al., bers are activated by cellular stresses (chemical, heat 1996) and p38γ ]. The amino acid sequence and osmotic shock, UV radiation, inhibitors of protein of SAPK2b is 73% identical to SAPK2a and it is inhibited synthesis), bacterial lipopolysaccharide (LPS), and the by SB 202190 at similar concentrations to SAPK2a. In cytokines interleukin-1 (IL1) and tumour necrosis factor contrast, the amino acid sequence of SAPK3 is only 60% (TNF), and have therefore been termed stress-activated identical to SAPK2a and SAPK2b, and SAPK3 is not protein kinases or SAPKs (reviewed in Cohen, 1997) .
inhibited by SB 203580 (Cuenda et al., 1997) . SAPK2b Isoforms of SAPK1 [also called c-Jun N-terminal kinases (JNKs)] phosphorylate Ser63 and Ser73 in the activation and SAPK3 have been introduced into mammalian cells by transient transfection and shown to be activated in response to pro-inflammatory cytokines and stressful stimuli in a manner similar to SAPK1 and SAPK2a. The physiological roles of SAPK2b and SAPK3 are unknown. The mRNAs encoding these enzymes are present in all mammalian tissues examined Mertens et al., 1996; Goedert et al., 1997) , with the mRNA encoding SAPK3 being most abundant in skeletal muscle. Expression of wild-type SAPK3 and an inactive mutant in the muscle cell line C2C12 respectively enhanced and inhibited differentiation into myotubes (Lechner et al., 1996) . In vitro, SAPK2b and SAPK3 phosphorylated several proteins that are also substrates for SAPK2a. SAPK2b was reported to phosphorylate the transcription factor ATF2 more efficiently than SAPK2a but, since the stress-and cytokine-induced phosphorylation of ATF2 in fibroblasts is unaffected by SB 203580 (Beyaert et al., 1996; Hazzalin et al., 1996) , neither SAPK2a nor SAPK2b appears to be rate-limiting for ATF2 phosphorylation in vivo, in contrast to earlier studies using transfection-based approaches (Gupta et al., 1995) . The substrate specificity of SAPK3 in vitro was similar to that of SAPK2a, except that it was much less effective in activating MAPKAP-K2/K3 and (like SAPK1, but unlike SAPK2a) phosphorylated ATF2 at Ser90, as well as at Thr69 and Thr71 (Cuenda et al., 1997) . However, whether SAPK1 and/or SAPK3 are rate-limiting for ATF2 phosphorylation in vivo is unknown. Five chromatographically distinct SAP kinase kinases , 1996; . In vitro, SKK1 [also single-letter code above the nucleotide sequence. The in-frame termed MKK4 (Dérijard et al., 1995) , SEK1 (Sanchez termination codon is marked by an asterisk.
et al., 1994) and XMEK2 (Yashar et al., 1993) ] activates all four SAPKs (Sanchez et al., 1994; Dérijard et al., 1995; Jiang et al., 1996; Results 1997), although SAPK2b and SAPK3 are phosphorylated Molecular cloning of human SAPK4 less efficiently. SKK2 [also termed MKK3 (Dérijard et al., To identify novel members of the SAPK family, we used 1995)] and SKK3 [also called MKK6
EST clone 156272 (GenBank accession number R72662), Moriguchi et al., 1996; Raingeaud et al., which encodes a portion of SAPK2b (p38β), as the 1996) and MEK6 (Stein et al., 1996) ] activate SAPK2a probe to screen a human pituitary gland cDNA library. but not SAPK1, while SKK3 was the only detectable Sequencing of positive clones showed three distinct activator of SAPK3 induced by pro-inflammatory cytosequences. The first set of clones encoded portions of kines and stressful stimuli in human epithelial KB cells ERK5 (Zhou et al., 1995) [also called BMK1 (Lee et al., or human embryonic kidney 293 cells (Cuenda et al., 1995) ], whereas the second set encoded a novel form of 1997). SKK3 was also the most efficient activator of p38β (see Discussion). The third set of clones encoded a SAPK2b in co-transfection experiments (Jiang et al., protein whose sequence was similar to, but differed from 1996). SKK4 and SKK5 activate SAPK1 but not SAPK2a that of known SAPKs and which was consequently named or SAPK3 (Cuenda et al., 1997) .
stress-activated protein kinase-4 (SAPK4). The nucleotide SKK4/SKK5 have not been purified or cloned and their and deduced amino acid sequence of human SAPK4 is amino acid sequences are thus still unknown.
shown in Figure 1 . An open reading frame encodes a In this paper, we report the cloning and characterization protein of 365 amino acids, with a predicted molecular of a novel MAP kinase family member that we call SAPK4.
mass of 42 kDa. It possesses the conserved amino acid This enzyme, which also contains a TGY sequence in domains (I-XI) characteristic of protein kinases and shows the activation domain, shows~60% identity to SAPK2a, 64% sequence identity with SAPK3, 59% identity with SAPK2b and SAPK3, and its mRNA is widely expressed SAPK2a, 58% identity with SAPK2b, 42% identity with in human tissues. We show that SAPK4 is activated by HOG1 from Saccharomyces cerevisiae (Figure 2 ), 45% the same stimuli that activate other SAP kinases and that identity with SAPK1 and 41% identity with p42 MAP SKK3 is likely to be the major upstream activator of kinase. Residues Thr180 and Tyr182 in subdomain VIII SAPK4 in vivo. The substrate specificity of SAPK4 in vitro are in an equivalent position to the TEY, TPY and TGY is similar to that of SAPK3 and, like SAPK3, SAPK4 is sequences in known MAP kinases and SAP kinases, phosphorylation of which is required for enzymatic not inhibited by SB 203580 or SB 202190.
activity. SAPK4 shares a TGY sequence with SAPK2a, human tissues was assessed by RNA blotting (Figure 3 ). Hybridization of 32 P-labelled SAPK4 cDNA to multiple SAPK2b, SAPK3 and HOG1 (Figure 2 ). Moreover, as in SAPK2a, SAPK2b, SAPK3 and HOG1, subdomain VII is tissue Northern blots showed a transcript of~2.3 kb which was present in most of the 16 tissues examined, albeit at separated by only six amino acids from the activation region in subdomain VIII (Figure 2 ), whereas this gap is variable levels (Figure 3 ). Highest levels were detected in pancreas, testis, small intestine and prostate gland. eight residues in SAPK1 and over 12 residues in MAP kinases. The tissue distribution of SAPK4 mRNA in Hybridization of the blots with a probe for β-actin showed approximately equal loading of RNA (data not shown).
SAPK4 is activated by cellular stresses and cytokines SAPK4 is most closely related to SAPK3, SAPK2a and SAPK2b, enzymes that are activated by cellular stresses and the cytokines IL1 and TNF (see Introduction). We therefore investigated whether the same stimuli would activate SAPK4. Human epithelial KB cells were transiently transfected with a myc epitope-tagged SAPK4 and, after exposure to cellular stresses or cytokines, the enzyme was immunoprecipitated and assayed. These experiments showed that the stimuli which trigger the activation of SAPK2a, SAPK2b or SAPK3 also activate SAPK4 ( Figure  4 ), while stimuli that do not activate SAPK2a, SAPK2b or SAPK3 [such as insulin-like growth factor-1 (IGF-1) and phorbol esters] also failed to activate SAPK4 (Figure 4 ).
Identification of SKK3 as the major activator of SAPK4 in epithelial cells
We have shown previously that SKK3 accounts for 95% and SKK2 for 5% of the SAPK2a activator detected after Mono S chromatography of lysates from KB cells that have been stressed in several ways or stimulated with IL1 Meier et al., 1996) . As shown in Figure 5 , the single peak of SAPK4 activator detected after subjecting KB cells to IL1 or the protein synthesis inhibitor anisomycin co-migrated with SKK3 on Mono S and was immunoprecipitated quantitatively and specifically by anti-MKK6 antibodies. This experiment also demonstrated that SKK4 and SKK5, which are activated in KB cells by these stimuli, and which elute from Mono S at a higher NaCl concentration than SKK3 , do not activate SAPK4. SKK3 was also the only activator of SAPK4 after subjecting KB cells to osmotic stress using sorbitol (data not shown). Further evidence that SKK3 can activate SAPK4 in vivo was obtained by co-transfection into COS cells. SAPK4 activity was elevated 12.5 Ϯ 0.63-fold by co-expression with SKK3 (n ϭ 3). In contrast, SAPK4 was not activated significantly by co-transfection with MEK kinase, under conditions where MEK kinase activated the endogenous SKK1 in COS cells (data not shown). Goedert et al., 1997) (also called ERK6 and p38γ), human SAPK2a (also called p38, p40, RK, CSBP2, Mxi2 and XMpk2), human SAPK2b (also called p38β) and HOG1 from S.cerevisiae (Brewster et al., 1993) . Amino acids were aligned and gaps were introduced to maximize the homology. Amino acid identities between at least three of the five sequences are indicated by black bars. Asterisks denote the dual phosphorylation sites in the TGY motif of the activation domain. The SAPK2b sequence shown here differs from the published p38β sequence (see Discussion). The amino acid sequence of SAPK3 (Goedert et al., 1997) differs in 13 positions from the ERK6 sequence of Lechner et al. (1996) and in 1 amino acid from the p38γ sequence of . Fig. 3 . RNA blot analysis of poly(A) ϩ RNA from adult human tissues, with 32 P-labelled SAPK4 DNA as the probe. Size markers (in kb) are marked to the left. Lanes: 1, heart; 2, brain; 3, placenta; 4, lung; 5, liver; 6, skeletal muscle; 7, kidney; 8, pancreas; 9, spleen; 10, thymus; 11, prostate gland; 12, testis; 13, ovary; 14, small intestine; 15, colon; 16, leucocytes. . Similar methods. Cells were stimulated in DMEM for 15 min with 0.5 M results were obtained in three different experiments. sorbitol, 1 mM H 2 O 2 , 20 ng/ml IL-1α, 0.5 mM sodium arsenite, 100 ng/ml TNFα, 100 ng/ml EGF or 300 ng/ml TPA; for 30 min with 10 μg/ml anisomycin or for 10 min with 100 ng/ml IGF-1. UV The activation of SAPK4 by SKK3 occurred 2-to 3-fold irradiation was at 60 J/m 2 and the cells were lysed 30 min later. more slowly than that of SAPK2a, although both enzymes Following stimulation, the myc epitope-tagged SAPK4 was attained the same specific activity towards myelin basic immunoprecipitated from cell lysates using monoclonal antibody 9E10 protein (MBP) after 2 h ( Figure 6A ). The activity of and the kinase activity measured using MBP as the substrate, as indicated in Materials and methods. The results are shown as the SAPK2a and SAPK4 towards MBP is 25-to 50-fold average Ϯ SEM of four experiments.
lower than the activity of p42 MAP kinase towards this substrate (Stokoe et al., 1992) . The activation of SAPK4, like that of SAPK3 (Cuenda et al., 1997) , reached a Activation of SAPK4 by SKK3 in vitro SAPK4 was activated in vitro by a highly purified preparplateau at~1.6 mol/mol subunit (data not shown) and was accompanied by the appearance of phosphotyrosine and ation of SKK3 from skeletal muscle (Figure 6 ), but could not be activated by MKK1 under conditions where p42 phosphothreonine in similar amounts ( Figure 6B ). Interestingly, SAPK4, like SAPK3 but unlike SAPK2a, also MAP kinase was activated maximally (data not shown). 5 μM, open circles) or MalE-Mpk2, the Xenopus homologue of SAPK2a (0.5 μM, closed circles), were phosphorylated using 100 U/ml SKK3 and unlabelled ATP and SAPK activities were measured at the times indicated using MBP as substrate. (B) GST-SAPK4, an inactive mutant GST-SAPK4(D168A) and Xenopus SAPK2a were phosphorylated for 2 h as in (A), but using [ 32 P]ATP (Cuenda et al., 1997) . Aliquots of the reactions were precipitated by the addition of 1 ml of 20% (by mass) TCA, the suspension centrifuged for 5 min at 13 000 g and the pellets washed three times with 20% (by mass) TCA, five times with water and dried. The samples were then incubated for 90 min at 110°C in 6 M HCl, electrophoresed on thin layer cellulose at pH 3.5 to resolve phosphoserine (pS), phosphothreonine (pT) and phosphotyrosine (pY), and autoradiographed. became phosphorylated at a serine residue(s). This did not occur when wild-type SAPK4 was replaced by the catalytically inactive SAPK4-D168A mutant ( Figure 6B ), indicating that serine phosphorylation is catalysed by SAPK4 itself after it has been activated. Interestingly, the inactive SAPK4 mutant could only be phosphorylated on tyrosine and not on threonine, indicating that this mutation induces a conformational change that affects the recognition of SAPK4 by SKK3.
Activation of SAPK4 by SKK1 (MKK4) in vitro
SAPK2 is not only phosphorylated by SKK2 and SKK3 in vitro, but also by SKK1 (MKK4) (see Introduction). SKK1 is activated by cytokines and cellular stresses and GST-SAPK4 (0.5 μM, open circles) or MalE-Mpk2, the Xenopus it was therefore of interest to investigate whether this homologue of SAPK2a (0.5 μM, closed circles) were incubated with enzyme also had the potential to activate SAPK4 in vitro.
100 U/ml SKK1 and unlabelled ATP and the generation of SAPK Figure 7 shows that SAPK4 is phosphorylated and activactivity measured at the times indicated using MBP as substrate.
ated by SKK1 in vitro, but at a much slower rate than SAPK2a under identical conditions. Consistent with this slow rate of activation, SAPK4 was not activated after SAPK4 is not inhibited by SB 203580 or SB 202190 Like SAPK3, bacterially expressed SAPK4 that had been co-transfection into COS1 cells with MEK kinase (data not shown), an upstream activator of SKK1. This is activated by SKK3 in vitro was not inhibited by SB 203580 or SB 202190 (Figure 9 ). In contrast, SAPK2a consistent with the negligible contribution of SKK1 to the SAPK4-activating activity in KB cell extracts ( Figure 5) . and SAPK2b were inhibited by both drugs with similar IC 50 values of 0.3-0.6 μM ( Figure 9 ). SB 203580 and SB 202190 also failed to inhibit the dephosphorylated forms Comparison of the substrate specificity of SAPK4 with that of SAPK2a, SAPK2b and SAPK3 of SAPK3 and SAPK4 which have Ͻ0.1% of the activity of the phosphorylated forms (data not shown). In addition, SAPK4 was more active than SAPK2a or SAPK2b in phosphorylating fusion proteins with glutathione S-trans-SB 203580 did not prevent the activation of transfected SAPK3 by osmotic shock in KB cells. ferase (GST) linked to the activation domains of the transcription factors Elk-1, ATF2, SAP-1, SAP-2 and p53, while c-Jun was only phosphorylated poorly by the three Discussion enzymes (Table I) . SAPK4 was far less effective than SAPK2a in activating GST-MAPKAP-K2(5-400) and
In this paper we report the cloning of the cDNA encoding human SAPK4, a novel MAP kinase family member full-length GST-MAPKAP-K3, the initial rate of activation of MAPKAP-K2 and MAPKAP-K3 and the half-time for whose mRNA is widely expressed and whose amino acid sequence is~60% identical to SAPK2a, SAPK2b and maximal activation being 20 times slower (Figure 8 ). The specificity of SAPK4 in vitro was similar to that of SAPK3 SAPK3. Moreover, SAPK4, like SAPK2a, SAPK2b and SAPK3, contains the dual TGY phosphorylation motif (Table I; Cuenda et al., 1997) . Consistent with their similar amino acid sequences (Figure 2) , the substrate specificities and a six amino acid insertion between subdomain VII and the activation loop in subdomain VIII. SAPK4 is less of SAPK2a and SAPK2b were virtually indistinguishable (Table I and Figure 8 ). similar to SAPK1 (45% identity) and p42/p44 MAP 
Experiments were carried out with the Xenopus homologue of SAPK2a, human SAPK2b and human SAPK4. The SAPKs were activated in vitro ( Figure 7 ) and phosphorylation of each protein was studied at a SAPK concentration of 0.15 U/ml. The results are presented as means Ϯ SEM of six determinations (two separate experiments). The data for rat SAPK3 are taken from Cuenda et al. (1997) .
kinases (41% identity). During the course of this study, we have also sequenced several cDNA clones for SAPK2b. They were found to encode a protein of 364 amino acids that differs from the published p38β sequence in two respects. It lacks an eight amino acid sequence between kinase subdomains V and VI and it shows two amino acid differences in this region. As a result, our SAPK2b sequence aligns with the other SAP kinase sequences without requiring any gaps. Consistent with its amino acid sequence similarity to SAPK2a, SAPK2b and SAPK3, SAPK4 is activated in response to the same cellular stresses and cytokines. The only activator of SAPK4 that could be detected in extracts prepared from epithelial KB cells exposed to a cellular stress or IL1 was SKK3, the product of the MKK6 gene. SAPK4 also became activated when co-transfected with SKK3 DNA into COS cells. In contrast, SAPK4 was activated poorly by SKK1 (MKK4) in vitro and was not activated in co-transfection experiments with MEK kinase, an upstream activator of SKK1 (Yan et al., 1994) . SAPK4 was also not activated by MKK1, SKK2 (MKK3), SKK4 or SKK5. Thus, SKK3 which is the dominant activator of SAPK2a , SAPK2b and SAPK3 (Cuenda et al., 1997) in several mammalian cell lines, also appears to be the major activator of SAPK4. is in disagreement with the work of who SAPK2b or SAPK4 were omitted. reported that the basal activity of bacterially expressed SAPK3 was inhibited by this drug. The reason for this discrepancy is unclear, because we failed to find any effect MAPKAP-K2 and MAPKAP-K3 than either SAPK2a or SAPK2b. The last mentioned result is consistent with the of SB 203580 or SB 202190 on either the basal activity of expressed SAPK3 or on SAPK3 that had been maximally finding that SB 203580 suppresses the stress-and cytokineinduced activation of MAPKAP-K2 and MAPKAP-K3 by activated by phosphorylation with SKK3. Identical results were obtained using bacterially expressed rat SAPK3 80-95% in every mammalian cell so far examined Beyaert et al., 1996; Clifton et al., 1996; (Cuenda et al., 1997) and human SAPK3.
The substrate specificity of SAPK4 in vitro resembled McLaughlin et al., 1996) . Moreover, although SAPK3 and SAPK4 phosphorylate the activation domain of the that of SAPK3 in that, while both enzymes phosphorylated a number of proteins (including the activation domains of transcription factor Elk-1 efficiently in vitro, neither enzyme appears to be rate-limiting for Elk-1 phosphorylseveral transcription factors) at similar rates to SAPK2a and SAPK2b, they were far less effective in activating ation in vivo, because Elk-1 phosphorylation induced by Following growth factor or phorbol ester stimulation, the MAP kinase kinases MKK1 and MKK2 (also called MEK1 and MEK2) activate the ERK1 and ERK2 group of MAP kinases. ERK1 and ERK2 (also termed p44 and p42 MAP kinases, respectively) phosphorylate a number of substrates, including the protein kinase MAPKAP-K1 (also called p90 rsk ) and the transcription factor Elk-1. In some cellular backgrounds, pro-inflammatory cytokines and cellular stresses also activate the MAP kinase pathway, albeit more weakly than growth factors or phorbol esters (indicated by brackets). Fig. 9 . Effects of SB 203580 or SB 202190 on SAPK2a, SAPK2b, SAP kinase (SAPK) pathways are strongly activated by pro-SAPK3 and SAPK4. The Xenopus homologue of SAPK2a (closed inflammatory cytokines and a large number of stressful stimuli. In some circles), human SAPK2b (open circles), human SAPK3 (closed cells they are also activated more weakly by certain growth factors triangles) and human SAPK4 (open triangles) were activated in vitro (indicated by brackets). The SAP kinase kinase SKK1 (also termed with purified SKK3, as in Figure 6 , and then assayed after a 10 min MKK4 and SEK1) activates SAPK1 (also called SAPK or JNK) which incubation with the indicated concentrations of SB 203580 or SB phosphorylates the transcription factor c-Jun. The highly homologous 202190. The results are presented relative to control incubations in SAPK1 isoforms are the products of three different genes. The SAP which the inhibitor was omitted.
kinase kinase SKK2 (also called MKK3) activates SAPK2a (also termed p38, RK, CSBP and Mxi2). The SAP kinase kinase SKK3 (also called MKK6 or MEK6) activates SAPK2a, SAPK2b (also termed p38β), cellular stresses can be prevented by SB 203580 in to SAPK1, SAPK2a, SAPK2b, SAPK3 and SAPK4, the 1 nmol of phosphate into MBP in 1 min. SAPK4 activators were assayed p42/p44 MAP kinases, which are strongly activated by by their ability to activate GST-SAPK4, as described previously for growth factors, are also activated by stressful stimuli and GST-SAPK3 (Cuenda et al., 1997) . Control experiments were carried pro-inflammatory cytokines in some cellular backgrounds, out in which GST-SAPK4 was omitted. One unit of SAPK4 activator albeit more weakly. Moreover, the MAP kinase family was the amount which increased SAPK4 activity by 1 U/min. MAPKAP-K2 and MAPKAP-K3 were assayed using the peptide KKLNRTLSVA member ERK5 (also called BMK1) is activated by osmotic as substrate (Rouse et al., 1994) and one unit of activity was the amount and oxidative stresses (Abe et al., 1996) . The development which catalysed the phosphorylation of 1 nmol of peptide substrate in of specific inhibitors for each of these MAP kinase family 1 min. SAPK2a activators were assayed by their ability to activate the members would greatly facilitate the elucidation of their
Xenopus laevis homologue of SAPK2a . Activated physiological roles.
SAPK2a itself was measured by the activation of GST-MAPKAP-K2(46-400). 0.1% DMSO was present in all experiments where the effects of SB 203580 and SB 202190 were being studied. This concentra-
Materials and methods
tion of DMSO inhibited each SAPK by~10%.
Materials
SB 203580 and SB 202190 were generous gifts from Dr John Lee Immunoprecipitation of SAPK4 (SmithKline Beecham, King of Prussia, PA, USA) and dissolved in
Lysates of cells transfected with myc epitope-tagged SAPK4 were DMSO. Anti-MKK6 antibodies (raised against the peptide CNPGLKEAcentrifuged at 4°C for 10 min at 13 000 g. Aliquots of the supernatant FEQPQTS corresponding to a sequence near the N-terminus of human (100 μg protein) were incubated for 2 h on a shaking platform with 5 μl MKK6) were generated and purified as described previously (Cuenda of protein G-Sepharose coupled to 3 μg of monoclonal antibody 9E10 et al., 1996; Meier et al., 1996) . MalE-Mpk2, the Xenopus homologue which recognizes the c-myc epitope. The immunoprecipitates were of SAPK2a (Rouse et al., 1994) and rat  washed and assayed as described (Cuenda et al., 1997) . 1997) were expressed in Escherichia coli and purified as described previously. Sources of all other materials, enzymes, fusion proteins and methods are given in Cuenda et al. (1997) .
